97O’Connor DT, Cadman PE, Smiley C, Salem RM, Rao F, Smith J, Funk SD, Mahata SK, Mahata
M, Wen G, Taupenot L, Gonzalez-Yanes C, Harper KL, Henry RR, Sanchez-Margalet V
(2005) Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation
in disease, and naturally occurring functional genetic polymorphism. J Clin Endocrinol Metab
90(9):5414–5425. doi:10.1210/jc.2005-0408
Pieroni M, Corti A, Tota B, Curnis F, Angelone T, Colombo B, Cerra MC, Bellocci F, Crea F,
Maseri A (2007) Myocardial production of chromogranin A in human heart: a new regulatory
peptide of cardiac function. Eur Heart J 28(9):1117–1127. doi:10.1093/eurheartj/ehm022
Portela-Gomes GM, Grimelius L, Wilander E, Stridsberg M (2010) Granins and granin-related pep-
tides in neuroendocrine tumours. Regul Pept 165(1):12–20. doi:10.1016/j.regpep.2010.02.011
Portel-Gomes GM, Grimelius L, Johansson H, Wilander E, Stridsberg M (2001) Chromogranin
A in human neuroendocrine tumors: an immunohistochemical study with region-specific anti-
bodies. Am J Surg Pathol 25(10):1261–1267
Radek KA, Lopez-Garcia B, Hupe M, Niesman IR, Elias PM, Taupenot L, Mahata SK, O’Connor
DT, Gallo RL (2008) The neuroendocrine peptide catestatin is a cutaneous antimicrobial
and induced in the skin after injury. J Invest Dermatol 128(6):1525–1534. doi:10.1038/
sj.jid.5701225
Ramella R, Boero O, Alloatti G, Angelone T, Levi R, Gallo MP (2010) Vasostatin 1 activates eNOS
in endothelial cells through a proteoglycan-dependent mechanism. J Cell Biochem 110(1):70–
- doi:10.1002/jcb.22510
Ratti S, Curnis F, Longhi R, Colombo B, Gasparri A, Magni F, Manera E, Metz-Boutigue MH, Corti
A (2000a) Structure-activity relationships of chromogranin A in cell adhesion. Identification
and characterization of an adhesion site for fibroblasts and smooth muscle cells. J Biol Chem
275(38):29257–29263
Ratti S, Curnis F, Longhi R, Colombo B, Gasparri A, Magni F, Manera E, Metz-Boutigue MH, Corti
A (2000b) Structure-activity relationships of chromogranin A in cell adhesion. Identification of
an adhesion site for fibroblasts and smooth muscle cells. J Biol Chem 275(38):29257–29263
Ribatti D (2009) Endogenous inhibitors of angiogenesis: a historical review. Leuk Res 33(5):638– - doi:10.1016/j.leukres.2008.11.019
Ribatti D, Nico B, Vacca A (2006) Importance of the bone marrow microenvironment in induc-
ing the angiogenic response in multiple myeloma. Oncogene 25(31):4257–4266. doi:10.1038/
sj.onc.1209456
Russell J, Gee P, Liu SM, Angeletti RH (1994) Inhibition of parathyroid hormone secretion by
amino-terminal chromogranin peptides. Endocrinology 135(1):337–342
Sanchez-Margalet V, Gonzalez-Yanes C, Najib S, Santos-Alvarez J (2010) Reprint of: metabolic
effects and mechanism of action of the chromogranin A-derived peptide pancreastatin. Regul
Pept 165(1):71–77. doi:10.1016/j.regpep.2010.10.004
Sanduleanu S, Stridsberg M, Jonkers D, Hameeteman W, Biemond I, Lundqvist G, Lamers C,
Stockbrugger RW (1999) Serum gastrin and chromogranin A during medium- and long-term
acid suppressive therapy: a case-control study. Aliment Pharmacol Ther 13(2):145–153
Schneider F, Bach C, Chung H, Crippa L, Lavaux T, Bollaert PE, Wolff M, Corti A, Launoy
A, Delabranche X, Lavigne T, Meyer N, Garnero P, Metz-Boutigue MH (2012) Vasostatin-I,
a chromogranin A-derived peptide, in non-selected critically ill patients: distribution, kinet-
ics, and prognostic significance. Intensive Care Med 38(9):1514–1522. doi:10.1007/
s00134-012-2611-3
Simon JP, Aunis D (1989) Biochemistry of the chromogranin A protein family. Biochem
J 262(1):1–13
Steiner HJ, Weiler R, Ludescher C, Schmid KW, Winkler H (1990) Chromogranins A and B are
co-localized with atrial natriuretic peptides in secretory granules of rat heart. J Histochem
Cytochem 38(6):845–850
Stridsberg M, Eriksson B, Oberg K, Janson ET (2004) A panel of 11 region-specific radioimmuno-
assays for measurements of human chromogranin A. Regul Pept 117(3):219–227
Chromogranin A in Endothelial Homeostasis and Angiogenesis